A Phase 1 Randomized Blinded Placebo-Controlled Single-Ascending-Dose Study to Evaluate the Safety Tolerability and Pharmacokinetics of BIIB076 in Healthy Volunteers and Subjects with Alzheimer's Disease

Currently Recruiting

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.